Overview
James Vredenburgh is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Vredenburgh is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, Brain Tumor, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 76 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Primitive Neuroectodermal Tumor (PNET).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Duke Cancer Center
I am a medical oncologist who specializes in the treatment of patients with skin cancer. I am part of a team of surgical oncologists, dermatologists, and radiation oncologists who all work together to determine the best treatment approach for each patient. My focus is on treating patients with advanced melanoma, as well as melanoma that is at high risk for recurrence after surgery. We also treat patients with merkel cell carcinoma and advanced basal cell and cutaneous squamous cell carcinoma. We also have a number of clinical trial options available, allowing our patients access to the newest therapies available. Dr. Salama is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Primitive Neuroectodermal Tumor (PNET).
University Of North Carolina At Chapel Hill
Frances Collichio is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Collichio is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Melanoma, Astrocytoma, Glioblastoma, and Oligodendroglioma.
Duke Cancer Center
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere. Dr. Crawford is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstrocytomaDr. Vredenburgh isElite. Learn about Astrocytoma.
- GlioblastomaDr. Vredenburgh isElite. Learn about Glioblastoma.
- GliomaDr. Vredenburgh isElite. Learn about Glioma.
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Vredenburgh isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Brain TumorDr. Vredenburgh isDistinguished. Learn about Brain Tumor.
- Breast Cancer in MenDr. Vredenburgh isDistinguished. Learn about Breast Cancer in Men.
- EGFR Positive Lung CancerDr. Vredenburgh isDistinguished. Learn about EGFR Positive Lung Cancer.
- Gliomatosis CerebriDr. Vredenburgh isDistinguished. Learn about Gliomatosis Cerebri.
- Large-Cell Lung CarcinomaDr. Vredenburgh isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Advanced
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Vredenburgh isAdvanced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Breast CancerDr. Vredenburgh isAdvanced. Learn about Breast Cancer.
- Embryonal Tumor with Multilayered RosettesDr. Vredenburgh isAdvanced. Learn about Embryonal Tumor with Multilayered Rosettes.
- EpendymomaDr. Vredenburgh isAdvanced. Learn about Ependymoma.
- GliosarcomaDr. Vredenburgh isAdvanced. Learn about Gliosarcoma.
- Inflammatory Breast CancerDr. Vredenburgh isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Vredenburgh isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Immune ThrombocytopeniaDr. Vredenburgh isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Vredenburgh isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Vredenburgh isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Vredenburgh isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Vredenburgh isExperienced. Learn about Angiosarcoma.
